Multimodal treatment options for bilobar colorectal liver metastases
about
Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatmentResection margin influences the outcome of patients with bilobar colorectal liver metastasesAnti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer.[Vascular replacement in abdominal tumor surgery].
P2860
Multimodal treatment options for bilobar colorectal liver metastases
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Multimodal treatment options for bilobar colorectal liver metastases
@ast
Multimodal treatment options for bilobar colorectal liver metastases
@en
Multimodal treatment options for bilobar colorectal liver metastases
@nl
type
label
Multimodal treatment options for bilobar colorectal liver metastases
@ast
Multimodal treatment options for bilobar colorectal liver metastases
@en
Multimodal treatment options for bilobar colorectal liver metastases
@nl
prefLabel
Multimodal treatment options for bilobar colorectal liver metastases
@ast
Multimodal treatment options for bilobar colorectal liver metastases
@en
Multimodal treatment options for bilobar colorectal liver metastases
@nl
P2093
P2860
P1476
Multimodal treatment options for bilobar colorectal liver metastases
@en
P2093
B Michael Ghadimi
Heinz Becker
Johannes Meller
Kia Homayounfar
Martin Niessner
Thomas Lorf
Torsten Liersch
P2860
P2888
P304
P356
10.1007/S00423-010-0604-7
P407
P577
2010-03-07T00:00:00Z